title banner

OR in the News

OR in the News (selected articles)

Duceppe E, Borges FK, Tiboni M, Pearse R, Chan MTV, Srinathan S, Kavsak PA, Garg AX, Sessler DI, Sapsford R, Heels-Ansdell D, Pettit S, Vasquez J, Mueller C, Walsh M, Szczeklik W, Rodseth R, Lalu M, Thabane L, Guyatt G, Devereaux PJ: High-sensitivity cardiac troponin I thresholds to identify myocardial injury after noncardiac surgery: A cohort study. Can J Cardiol 2023; 39: 311-318

July 27, 2023

Myocardial injury after noncardiac surgery (MINS) is common and associated with short- and long-term major cardiovas- cular events. Diagnostic criteria for MINS using Abbott high-sensitivity cardiac troponin I (hs-cTnI) are unknown.
We performed a prospective cohort study of adults who had in-patient noncardiac surgery and measured hs-cTnI (Abbott Labora- tories) on postoperative serum samples collected up to postoperative day 3. The objective was to determine prognostically important hs-cTnI thresholds associated with major cardiac events and death at 30 days after noncardiac surgery. Using Cox proportional iterative analyses, we determined peak postoperative hs-cTnI thresholds associated with the occurrence of the 30-day composite of major cardiac events (ie, nonfatal myocardial infarction after 3 postoperative days, cardiac ar- rest, and congestive heart failure) and death.
Of 3953 included patients, 66 (1.7%) experienced the pri- mary outcome at 30 days. Peak hs-cTnI values and associated inci- dence of major cardiac events and death were as follows: < 60 ng/L: 1.0% (95% CI 0.7-1.3); 60 to < 700 ng/L: 8.6% (5.6-13.0); and  700 ng/L: 27.3% (16.4-41.9). Compared with peak hs-cTnI < 60 ng/L, adjusted hazard ratios were 7.54 (95% CI% 4.27-13.32) for hs-cTnI values of 60 to < 700 ng/L and 26.87 (13.27-54.41) for values  700 ng/L. Conclusions:
Hs-cTnI elevation within the first 3 days after noncardiac surgery independently predicts major cardiac events and death at 30 days. A postoperative hs-cTnI  60 ng/L was associated with a > 7- fold increase in the risk of subsequent major cardiac events and mortality at 30 days.